CD8A and neoplasm: Further analysis revealed that for the primary MC38 tumor, LID + US + αPD-L1 enhanced the intratumoral CD8 + T cell infiltration by 170% and 70% compared with the untreated group (P < 0.05) and LID + US (P < 0.05), respectively (Fig. 6f, g).